Click on image to view larger version.

Figure 1 Relative risks for primary combined end point events (death, myocardial infarction, target vessel revascularization) within six-month follow-up according to the presence or absence of elevated C-reactive protein (CRP) levels (above median value 0.6 mg/dl) or presence or absence of statin treatment in patients following coronary stent implantation.